Global perspectives on agricultural biotechnology
Upcoming SlideShare
Loading in...5
×
 

Global perspectives on agricultural biotechnology

on

  • 1,412 views

Global soil regions,biotech and yields,Agricultural Biotechnology Investment,Biotech and Nigeria’s Future

Global soil regions,biotech and yields,Agricultural Biotechnology Investment,Biotech and Nigeria’s Future

Statistics

Views

Total Views
1,412
Views on SlideShare
1,408
Embed Views
4

Actions

Likes
0
Downloads
33
Comments
0

2 Embeds 4

http://paper.li 3
http://unjobs.org 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

CC Attribution-NonCommercial LicenseCC Attribution-NonCommercial License

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Global perspectives on agricultural biotechnology Global perspectives on agricultural biotechnology Presentation Transcript

  • Global Perspectives onAgricultural Biotechnology By Gary R. Blumenthal At IITA Ibadan, Nigeria 31 August 2009
  • Speaker’s Biases• Desktop Farmer (Information products)• Fundamental S&D; Policy Overlay• Since 1980• Global Analysts• Clients • Multinationals: ABC’s, Inputs • Food Processors • Financial Institutions • Hedge Funds • Farmers/Cooperatives• Consulting Projects
  • Quiza. Selective Breedingb. Genetically modified via biotechnologyc. Nollywood
  • “African countries need to think andoperate as stakeholders, rather thanaccepting the „victim mentality‟ created inEurope.”Florence Wambugu ISAAA
  • Biotech and Yields•U.S. yields outpaceEU•Productivity+4.4%/year•GM Wheatagreement
  • Agricultural Investment • Food processing has captured just 10% of cross-border investment; • Production agriculture received just 0.0006%
  • Ag Biotechnology Investment• US$8.6 billion Venture capital investment in life sciences in 2007.• One-third of all venture capital in U.S., Canada and Sweden in life sciences.
  • Efficient Regulatory ManagementHigh cost ofregulatorycompliance is Componentsone of thereasons • National Biosafety Policydelayingrelease of • Regulatory Regime (objective)events in • Transparent Administrative systemdeveloping • Public Awareness and Participationcountries. • System for Follow-upFAO
  • 2-5 years, all new crops.Excessive regulation has its impact.
  • Publicly Supported GM Field Trials
  • Pace Grows Exponentially1,000,000,000 Single molecule? 100,000,000 Massively parallel sequencing Short-read 10,000,000 sequencers 1,000,000 Microwell Capillary pyrosequenc ing 100,000 sequencing Second- 10,000 Gel-based generation systems capillary Automated sequencer 1,000 First- Manual Slab Slab Gel generation Gel 100 capillary
  • Still Debating Last Century’s Technology Metabolic Pathway Engineering Synthetic Biology Nanotechnology Transgenics Mutagenisis CloningSelective Breeding and Hybridization
  • Biotech and Nigeria’s Future • Hunger • Health/Output TraitsPresidentYar’adua: • Disease/Insect/Herbicide ResistanceNot just food • Nitrogen Fixingsecurity butagriculture as a • Drought Resistancemajor foreignexchange • Salinity Toleranceearner by 2020. • Climate Change (both GHG reduction and adaptation) • Energy
  • Conclusions
  • Thank you.